Vistin Pharma ASA

OB:VISTN Stock Report

Market Cap: NOK 1.1b

Vistin Pharma Dividends and Buybacks

Dividend criteria checks 3/6

Vistin Pharma is a dividend paying company with a current yield of 4.1% that is well covered by earnings.

Key information

4.1%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growth11.5%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareNOK 1.000
Payout ratio72%

Recent dividend and buyback updates

Recent updates

Here's Why Vistin Pharma (OB:VISTN) Has Caught The Eye Of Investors

Sep 18
Here's Why Vistin Pharma (OB:VISTN) Has Caught The Eye Of Investors

Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

Feb 23
Would Vistin Pharma (OB:VISTN) Be Better Off With Less Debt?

A Look At The Fair Value Of Vistin Pharma ASA (OB:VISTN)

Sep 09
A Look At The Fair Value Of Vistin Pharma ASA (OB:VISTN)

Robust Earnings May Not Tell The Whole Story For Vistin Pharma (OB:VISTN)

Aug 25
Robust Earnings May Not Tell The Whole Story For Vistin Pharma (OB:VISTN)

Investors In Vistin Pharma ASA (OB:VISTN) Should Consider This, First

Mar 15
Investors In Vistin Pharma ASA (OB:VISTN) Should Consider This, First

We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Feb 20
We're Keeping An Eye On Vistin Pharma's (OB:VISTN) Cash Burn Rate

Could The Vistin Pharma ASA (OB:VISTN) Ownership Structure Tell Us Something Useful?

Jan 29
Could The Vistin Pharma ASA (OB:VISTN) Ownership Structure Tell Us Something Useful?

The Vistin Pharma (OB:VISTN) Share Price Is Up 119% And Shareholders Are Boasting About It

Jan 08
The Vistin Pharma (OB:VISTN) Share Price Is Up 119% And Shareholders Are Boasting About It

Have Insiders Been Selling Vistin Pharma ASA (OB:VISTN) Shares?

Dec 16
Have Insiders Been Selling Vistin Pharma ASA (OB:VISTN) Shares?

Is Vistin Pharma ASA (OB:VISTIN) At Risk Of Cutting Its Dividend?

Nov 26
Is Vistin Pharma ASA (OB:VISTIN) At Risk Of Cutting Its Dividend?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: VISTN has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: VISTN's dividend payments have increased, but the company has only paid a dividend for 9 years.

Dividend Yield vs Market

Vistin Pharma Dividend Yield vs Market
How does VISTN dividend yield compare to the market?
SegmentDividend Yield
Company (VISTN)4.1%
Market Bottom 25% (NO)3.3%
Market Top 25% (NO)7.9%
Industry Average (Pharmaceuticals)2.7%
Analyst forecast (VISTN) (up to 3 years)n/a

Notable Dividend: VISTN's dividend (4.1%) is higher than the bottom 25% of dividend payers in the Norwegian market (3.35%).

High Dividend: VISTN's dividend (4.1%) is low compared to the top 25% of dividend payers in the Norwegian market (7.93%).

Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (72.3%), VISTN's dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: At its current cash payout ratio (79.5%), VISTN's dividend payments are covered by cash flows.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 12:47
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vistin Pharma ASA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mikkel Nyholt-SmedsengCarnegie Investment Bank AB